Remgro Ltd JSE:REM:
JSE: REM - FURTHER CAUTIONARY ANNOUNCEMENT REGARDING A POTENTIAL RESTRUCTURING OF INTERESTS IN MEDICLINIC HOLDINGS
REMGRO - NEGOTIATIONS ON POTENTIAL RESTRUCTURING IN MEDICLINIC HOLDINGS ARE ONGOING
Remgro Says Negotiations On Potential Mediclinic Restructuring Ongoing
Watch Remgro's latest callRemgro (JSE:REM) Q2 2026 Earnings Call · Replay · Mar 25Read the transcript of Remgro (JSE:REM) Q2 2026 Earnings CallEarlier from Remgro
- Remgro Says 1: 1 Equity Value Exchange Ratio Envisaged For Mediclinic And Hirslanden
- REM: Headline earnings up 38.6%, dividends and cash flow surged, with strong portfolio performance
- REM: Maziv's ZAR 36bn deal advances with regulatory support, major CapEx, and BEE commitments
- REM: Portfolio now 63% private, with growth led by Mediclinic and CIVH, and focus on performance
- REM: Headline earnings up 38.7%, dividend up 20%, and Heineken Beverages returns to profitability
Later from Remgro
- Remgro Sells About 52 Million Additional Firstrand Shares
- REM: HEPS expected to rise 36%–41% year-over-year for the six months ended 31 December 2025
- REM: Earnings up 38.8% and interim dividend up 80%, with strong cash generation and portfolio gains
- Remgro Enters Agreement To Restructure Interests In Mediclinic Group With IHL
Follow Remgro into a list and get an email when it puts out news.
Follow Remgro